Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while it ...

Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...

A diagnosis of prostate cancer can stir up fear and worry. Thats especially true when its metastatic prostate cancer, also known as stage 4 prostate cancer, that has spread from the prostate to other ...

Adding darolutamide to standard treatment for aggressive prostate cancer reduced the risk of the disease spreading in an ...